ROYAL BANK OF CANADA - ZENTALIS PHARMACEUTICALS INC ownership

ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 120 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.3%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ZENTALIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$24,000
-47.8%
5,900
+104.7%
0.00%
Q1 2024$46,000
-82.7%
2,882
-83.6%
0.00%
Q4 2023$266,000
+72.7%
17,527
+129.1%
0.00%
Q3 2023$154,000
+65.6%
7,649
+132.1%
0.00%
Q2 2023$93,000
+102.2%
3,296
+22.9%
0.00%
Q1 2023$46,000
-71.4%
2,681
-66.2%
0.00%
Q4 2022$161,000
+1138.5%
7,930
+1228.3%
0.00%
Q3 2022$13,000
-96.8%
597
-95.9%
0.00%
Q2 2022$409,000
-46.4%
14,553
-12.0%
0.00%
Q1 2022$763,000
-60.3%
16,546
-27.7%
0.00%
Q4 2021$1,924,000
+736.5%
22,893
+562.8%
0.00%
Q3 2021$230,000
+90.1%
3,454
+51.8%
0.00%
Q2 2021$121,000
+17.5%
2,276
-3.8%
0.00%
Q1 2021$103,000
+194.3%
2,365
+254.0%
0.00%
Q4 2020$35,000
+3400.0%
668
+2469.2%
0.00%
Q3 2020$1,0000.0%26
+18.2%
0.00%
Q2 2020$1,000220.00%
Other shareholders
ZENTALIS PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Decheng Capital Management III (Cayman), LLC 2,099,583$42,117,63514.06%
Mayo Clinic 187,143$3,754,0897.23%
Matrix Capital Management Company, LP 13,959,973$280,037,0583.36%
5AM Venture Management, LLC 490,000$9,829,4002.83%
Eventide Asset Management 7,814,039$156,749,6222.82%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 961,486$19,287,4102.70%
Avidity Partners Management LP 2,100,000$42,126,0001.70%
First Light Asset Management, LLC 848,477$17,020,4491.62%
Sofinnova Investments, Inc. 1,211,641$24,305,5181.53%
SECTORAL ASSET MANAGEMENT INC 386,525$7,753,6921.51%
View complete list of ZENTALIS PHARMACEUTICALS INC shareholders